Additionally, the 36-month beta value for GMRE is 1.26. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for GMRE is 63.03M and currently, short sellers hold a 1.61% ratio of that float. The average trading volume of GMRE on December 20, 2024 was 382.12K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GMRE) stock’s latest price update
Global Medical REIT Inc (NYSE: GMRE)’s stock price has gone decline by -0.75 in comparison to its previous close of 7.95, however, the company has experienced a -6.74% decrease in its stock price over the last five trading days. seekingalpha.com reported 2024-12-10 that Most REITs are well-positioned to grow dividends. But there are exceptions. I highlight three REITs that are at high risk of cutting their dividend.
GMRE’s Market Performance
Global Medical REIT Inc (GMRE) has seen a -6.74% fall in stock performance for the week, with a -8.68% decline in the past month and a -19.41% plunge in the past quarter. The volatility ratio for the week is 2.77%, and the volatility levels for the past 30 days are at 2.01% for GMRE. The simple moving average for the last 20 days is -7.77% for GMRE’s stock, with a simple moving average of -12.41% for the last 200 days.
Analysts’ Opinion of GMRE
Many brokerage firms have already submitted their reports for GMRE stocks, with Berenberg repeating the rating for GMRE by listing it as a “Buy.” The predicted price for GMRE in the upcoming period, according to Berenberg is $11.75 based on the research report published on October 18, 2024 of the current year 2024.
Alliance Global Partners, on the other hand, stated in their research note that they expect to see GMRE reach a price target of $12. The rating they have provided for GMRE stocks is “Buy” according to the report published on September 19th, 2024.
Robert W. Baird gave a rating of “Neutral” to GMRE, setting the target price at $9 in the report published on October 10th of the previous year.
GMRE Trading at -11.23% from the 50-Day Moving Average
After a stumble in the market that brought GMRE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.89% of loss for the given period.
Volatility was left at 2.01%, however, over the last 30 days, the volatility rate increased by 2.77%, as shares sank -9.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.50% lower at present.
During the last 5 trading sessions, GMRE fell by -6.91%, which changed the moving average for the period of 200-days by -11.12% in comparison to the 20-day moving average, which settled at $8.55. In addition, Global Medical REIT Inc saw -28.92% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GMRE
Current profitability levels for the company are sitting at:
- 0.36 for the present operating margin
- 0.64 for the gross margin
The net margin for Global Medical REIT Inc stands at 0.03. The total capital return value is set at 0.09. Equity return is now at value 0.77, with 0.35 for asset returns.
Based on Global Medical REIT Inc (GMRE), the company’s capital structure generated 0.54 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.16. The interest coverage ratio of the stock is 1.63.
Currently, EBITDA for the company is 111.64 million with net debt to EBITDA at 6.26. When we switch over and look at the enterprise to sales, we see a ratio of 7.98. The receivables turnover for the company is 17.9for trailing twelve months and the total asset turnover is 0.12.
Conclusion
In conclusion, Global Medical REIT Inc (GMRE) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
